Nature's Sunshine Products Inc. (NATR)
NASDAQ (CM) NASDAQ (CM) Primary 
PSX 
Nature's Sunshine Products Q1 Earnings Call Highlights
Nature's Sunshine Products NASDAQ: NATR reported what management called a “very strong” start to 2026, highlighting first-quarter sales growth of 9% and adjusted EBITDA growth of 33% as the company continued to push deeper into digital channels and subscription programs while expanding its consultant base globally.
Nature's Sunshine Products, Inc. (NATR) Q1 2026 Earnings Call Transcript
Nature's Sunshine Products, Inc. (NATR) Q1 2026 Earnings Call Transcript
Nature's Sunshine Products, Inc. (NATR) Q4 2025 Earnings Call Transcript
Nature's Sunshine Products, Inc. (NATR) Q4 2025 Earnings Call Transcript
Nature's Sunshine Looks Fairly Priced After Its Recent Rally
Nature's Sunshine delivered strong Q3 2025 results, driven by robust growth in Asia and recurring autoship sales. NATR's international focus, especially in Asia and Europe, positions it for continued growth, though its MLM model may cause choppy performance. Despite a strong balance sheet, buybacks, and premium margins, NATR's current valuation reflects its strengths, and it trades at a premium to other MLMs.
Nature's Sunshine Products, Inc. (NATR) Q3 2025 Earnings Call Transcript
Nature's Sunshine Products, Inc. ( NATR ) Q3 2025 Earnings Call November 6, 2025 5:00 PM EST Company Participants Nathan Brower - Executive VP, General Counsel & Secretary Kenneth Romanzi - CEO & Director Shane Jones - Executive VP of Finance, CFO & Treasurer Conference Call Participants Brian Holland - D.A. Davidson & Co., Research Division Presentation Operator Good afternoon, everyone, and thank you for participating in today's conference call to discuss Nature's Sunshine's financial results for the third quarter ended September 30, 2025.
Nature's Sunshine: Premium Valuation Without Moats, Sell
Nature's Sunshine is a leading U.S.-based herbal supplement manufacturer founded in 1972, operating a Multi-Level Marketing model. Nature's Sunshine (NATR) is trading at a 16.4x forward P/E, a premium compared to the peer average of 14.2x, and higher than companies like Herbalife (4.1x) and USANA (11.2x). The company's forward revenue growth of 2.8% and mixed EPS outlook do not justify the premium valuation, especially when compared to competitors like LifeVantage, which has a 26.6% CAGR EPS.
Nature's Sunshine Products, Inc. (NATR) Q2 2025 Earnings Call Transcript
Nature's Sunshine Products, Inc. (NASDAQ:NATR ) Q2 2025 Earnings Conference Call July 31, 2025 5:00 PM ET Company Participants L. Shane Jones - Executive VP of Finance, CFO & Treasurer Nathan G.
Nature's Sunshine Products, Inc. (NATR) Q1 2025 Earnings Call Transcript
Nature's Sunshine Products, Inc. (NASDAQ:NATR ) Q1 2025 Earnings Conference Call May 6, 2025 5:00 PM ET Company Participants Terrence Moorehead - CEO Shane Jones - CFO Nate Brower - General Counsel Conference Call Participants Brian Holland - Davidson Susan Anderson - Canaccord Genuity Operator Good afternoon, everyone. And thank you for participating in today's conference call to discuss Nature's Sunshine's Financial Results for the First Quarter Ended March 31, 2025.
Nature's Sunshine Products: Near-Term Weakness But Attractive Entry Point For Long-Term Investors
Nature's Sunshine Products offers a compelling long-term investment opportunity, trading at a 35% discount to historical averages. Despite weak North American demand, NATR's digital strategies and Asia-Pacific market success, particularly in Taiwan, Japan, and Korea, should sustain revenue growth. Margins are expected to remain flat or slightly down in FY2025 due to inflationary pressures, but cost-saving initiatives should provide some relief.
Nature's Sunshine Products, Inc. (NATR) Q4 2024 Earnings Call Transcript
Nature's Sunshine Products, Inc. (NASDAQ:NATR ) Q4 2024 Results Conference Call March 11, 2025 5:00 PM ET Company Participants Nate Brower - General Counsel Terrence Moorehead - Chief Executive Officer Shane Jones - Chief Financial Officer Conference Call Participants Susan Anderson - Canaccord Linda Bolton-Weiser - D.A. Davidson Operator Good afternoon, everyone, and thank you for participating in today's conference call to discuss Nature's Sunshine's Financial Results for the Fourth Quarter and Full Year Ended December 31, 2024.
Nature's Sunshine Products, Inc. (NATR) Q3 2024 Earnings Call Transcript
Nature's Sunshine Products, Inc. (NASDAQ:NATR ) Q3 2024 Earnings Conference Call November 7, 2024 5:00 PM ET Company Participants Nate Brower - General Counsel Terrence Moorehead - Chief Executive Officer Shane Jones - Chief Financial Officer Conference Call Participants Susan Anderson - Canaccord Genuity Linda Bolton-Weiser - D.A. Davidson Operator Good afternoon, everyone and thank you for participating in today's Conference Call to discuss Nature's Sunshine's Financial Results for the Third Quarter Ended September 30, 2024.
Nature's Sunshine Products: Cheap, But Not Entirely Without A Reason To Be
Nature's Sunshine Products is a small wellness company with a market cap of $243.8 million, trading at low multiples, with no debt and significant cash reserves. The company has a diverse product range and significant revenue from Asia, but financial performance has been volatile, particularly in North America and Europe. Despite recent revenue declines and mixed profitability metrics, the company has seen some recovery due to strong growth in Asia and strategic initiatives.
